Fingerprint
Dive into the research topics of 'Phase I clinical and pharmacologic study of weekly cisplatin and irinotecan combined with amifostine for refractory solid tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I clinical and pharmacologic study of weekly cisplatin and irinotecan combined with amifostine for refractory solid tumors
Abdul Kader Souid, Ronald L. Dubowy, Susan M. Blaney, Linda Hershon, Jim Sullivan, Wendy D. McLeod, Mark L. Bernstein
Research output: Contribution to journal › Article › peer-review
27
Citations
(Scopus)